@prefix this: . @prefix rdfs: . @prefix xsd: . @prefix sio: . @prefix ncit: . @prefix lld: . @prefix miriam-gene: . @prefix miriam-pubmed: . @prefix eco: . @prefix wi: . @prefix prov: . @prefix pav: . @prefix prv: . @prefix dcterms: . @prefix np: . @prefix dgn-np: . @prefix dgn-gda: . @prefix dgn-void: . dgn-np:NP467475.RAfbJNSFlzUxyzJ0_6AoXfpGbipb8H_vwGm028PDCxjwM130_head { this: np:hasAssertion dgn-np:NP467475.RAfbJNSFlzUxyzJ0_6AoXfpGbipb8H_vwGm028PDCxjwM130_assertion; np:hasProvenance dgn-np:NP467475.RAfbJNSFlzUxyzJ0_6AoXfpGbipb8H_vwGm028PDCxjwM130_provenance; np:hasPublicationInfo dgn-np:NP467475.RAfbJNSFlzUxyzJ0_6AoXfpGbipb8H_vwGm028PDCxjwM130_publicationInfo; a np:Nanopublication . dgn-np:NP467475.RAfbJNSFlzUxyzJ0_6AoXfpGbipb8H_vwGm028PDCxjwM130_assertion a np:Assertion . dgn-np:NP467475.RAfbJNSFlzUxyzJ0_6AoXfpGbipb8H_vwGm028PDCxjwM130_provenance a np:Provenance . dgn-np:NP467475.RAfbJNSFlzUxyzJ0_6AoXfpGbipb8H_vwGm028PDCxjwM130_publicationInfo a np:PublicationInfo . } dgn-np:NP467475.RAfbJNSFlzUxyzJ0_6AoXfpGbipb8H_vwGm028PDCxjwM130_assertion { miriam-gene:5728 a ncit:C16612 . lld:C0019562 a ncit:C7057 . dgn-gda:DGN04dd5e05663a9a7ef689b756a8996df9 sio:SIO_000628 miriam-gene:5728, lld:C0019562; a sio:SIO_001121 . } dgn-np:NP467475.RAfbJNSFlzUxyzJ0_6AoXfpGbipb8H_vwGm028PDCxjwM130_provenance { dgn-np:NP467475.RAfbJNSFlzUxyzJ0_6AoXfpGbipb8H_vwGm028PDCxjwM130_assertion dcterms:description "[In comparison with the normal mucosa of the non-cancer patients, the following 14 genes displayed no tumor associated changes: breast cancer 1, early onset (BRCA1), cadherin 1, type 1, E-cadherin (epithelial) (CDH1), death-associated protein kinase 1 (DAPK1), DNA (cytosine-5-)-methyltransferase 1 (DNMT1), melanoma antigen, family A, 1 (directs expression of antigen MZ2-E) (MAGEA1), tumor suppressor candidate 3 (N33), cyclin-dependent kinase inhibitor 1A (p21, Cip1) (p21(WAF1)), cyclin-dependent kinase inhibitor 1B (p27, Kip1) (p27(KIP1)), phosphatase and tensin homolog (mutated in multiple advanced cancers 1) (PTEN), retinoic acid receptor, beta (RAR- , Ras association (RalGDS/AF-6) domain family 1 C (RASSF1C), secreted frizzled-related protein 1 (SFRP1), tissue inhibitor of metalloproteinase 3 (Sorsby fundus dystrophy, pseudoinflammatory) (TIMP3), and von Hippel-Lindau syndrome (VHL).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en; wi:evidence dgn-void:source_evidence_literature; sio:SIO_000772 miriam-pubmed:15526363; prov:wasDerivedFrom dgn-void:befree-2016; prov:wasGeneratedBy eco:ECO_0000203 . dgn-void:befree-2016 pav:importedOn "2016-02-19"^^xsd:date . dgn-void:source_evidence_literature a eco:ECO_0000212; rdfs:comment "Gene-disease associations inferred from text-mining the literature."@en; rdfs:label "DisGeNET evidence - LITERATURE"@en . } dgn-np:NP467475.RAfbJNSFlzUxyzJ0_6AoXfpGbipb8H_vwGm028PDCxjwM130_publicationInfo { this: dcterms:created "2016-05-13T12:45:16+02:00"^^xsd:dateTime; dcterms:rights ; dcterms:rightsHolder dgn-void:IBIGroup; dcterms:subject sio:SIO_000983; prv:usedData dgn-void:disgenetv3.0rdf; pav:authoredBy , , , , ; pav:createdBy ; pav:version "v4.0.0.0" . dgn-void:disgenetv3.0rdf pav:version "v4.0.0" . }